An official website of the United States government
Outcomes of infants born to women infected with Hepatitis B virus and managed by the CDC Perinatal Hepatitis B Prevention Program, by birth cohort year — 56 US Jurisdictions,* 2009–2020
Source: CDC, National Perinatal Hepatitis B Prevention Program (PHBPP). Infants managed: Number of infants case managed by the PHBPP.
PEP (postexposure prophylaxis): Number of infants who received PEP (hepatitis B immune globulin and 1st dose of hepatitis B vaccine) for hepatitis B virus infection.
PVST (postvaccination serological testing): Number of infants who received PVST after hepatitis B vaccine series completion.
* Includes 50 states, District of Columbia, and five cities. Excludes territories and freely associated island nations.
The number of infants whose care was managed in the CDC Perinatal Hepatitis B Prevention Program from 50 states, District of Columbia, and five cities was 11,551 in 2009 and 7,583 in 2020. During 2009-2020, the percentage of infants who received PEP has remained relatively stable between 95% to 97% each year. The percentage of infants who received PVST has increased from 59% (6,792 of 11,551 infants managed) in 2009 to 65% (4,960 of 7,583 infants managed) in 2020.